Characterization of parvovirus B19 genotype 2 in KU812Ep6 cells

Journal of Virology

Volumn 79, Issue 22, 2005, Pages 14197-14206

  Blümel, Johannes ^a   Eis Hübinger, Anna Maria ^b   Stühler, Albert ^a   Bönsch, Claudia ^a   Gessner, Matthias ^c   Löwer, Johannes ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c BAXTER BIOSCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; VIRUS DNA;

AMINO ACID SEQUENCE; ANTIGENICITY; ARTICLE; BLOOD DONOR; CELL STRAIN KU812EP6; CONTROLLED STUDY; DNA REPLICATION; ERYTHROID CELL; GENE IDENTIFICATION; GENE INSERTION; GENE SEQUENCE; GENOME ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PARVOVIRUS; PH; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; VIRUS CAPSID; VIRUS GENE; VIRUS INACTIVATION; VIRUS NEUTRALIZATION;

BASE SEQUENCE; CELL LINE; CONSERVED SEQUENCE; DNA PRIMERS; GENOTYPE; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID; VIREMIA;

DNA VIRUSES; MIRIDAE; PARVOVIRUS;

EID: 27644445077     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.22.14197-14206.2005     Document Type: Article

References (37)

1. Aberham, C., C. Pendel, P. Gross, G. Zerlauth, and M. Gessner. 2001. A quantitative internally controlled real-time PCR assay for the detection of parvovirus B19 DNA. J. Virol. Methods 92:183-191.
2. Agbandje, M., S. Kajigaya, R. McKenna, N. S. Young, and M. G. Rossmann. 1994. The structure of human parvovirus B19 at 8 A resolution. Virology 203:106-115.
3. Aubin, J. T., C. Defer, M. Vidaud, M. M. Maniez, and B. Flan. 2000. Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation. Vox Sang. 78:7-12.
4. Azzi, A., M. Morfini, and P. M. Mannucci. 1999. The transfusion- associated transmission of parvovirus B19. Transfus. Med. Rev. 13:194-204.
5. Blümel, J., I. Schmidt, H. Willkommen, and J. Löwer. 2002. Inactivation of parvovirus B19 during pasteurization of human serum albumin. Transfusion 42:1011-1018.
6. Blümel, J., I. Schmidt, W. Efenberger, H. Seitz, H. Willkommen, H. H. Brackmann, J. Löwer, and A. M. Eis-Hübinger. 2002. Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion 42:1473-1481.
7. Boschetti, N., I. Niederhauser, C. Kempf, A. Stühler, J. Löwer, and J. Blumel. 2004. Different susceptibility of B19 virus and mice minute virus to low pH treatment. Transfusion 44:1079-1086.
8. Brown, C. S., T. Jensen, R. H. Meloen, W. Puijk, K. Sugamura, H. Sato, and W. J. Spaan. 1992. Localization of an immunodominant domain on baculovirus-produced parvovirus B19 capsids: correlation to a major surface region on the native virus particle. J. Virol. 66:6989-6996.
9. Candotti, D., N. Etiz, A. Parsyan, and J. P. Allain. 2004. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J. Virol. 78:12169-12178.
10. Deiss, V., J. D. Tratschin, M. Weitz, and G. Siegl. 1990. Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini. Virology 175:247-254.
11. Ferguson, M., D. Walker, and B. Cohen. 1997. Report of a collaborative study to establish the international standard for parvovirus B19 serum IgG. Biologicals 25:283-288.
12. Gallinella, G., S. Venturoli, E. Manaresi, M. Musiani, and M. Zerbini. 2003. B19 virus genome diversity: epidemiological and clinical correlations. J. Clin. Virol. 28:1-13.
13. Gareus, R., A. Gigler, A. Hemauer, M. Leruez-Ville, F. Morinet, H. Wolf, and S. Modrow. 1998. Characterization of cis-acting and NS1 protein-responsive elements in the p6 promoter of parvovirus B19. J. Virol. 72:609-616.
14. Hall, T. A. 1999. BioEdit: a user friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
15. Hokynar, K., M. Söderlund-Venermo, M. Pesonen, A. Ranki, O. Kiviluoto, E. K. Partio, and K. Hedman. 2002. A new parvovirus genotype persistent in human skin. Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue. Virology 302:224-228.
16. Kärber, G. 1931. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch. Exp. Pathol. Pharmakol. 162:480-483.
17. Kaufmann, B., A. A. Simpson, and M. G. Rossmann. 2004. The structure of human parvovirus B19. Proc. Natl. Acad. Sci. USA 101:11628-11633.
18. Liefeldt, L., A. Plentz, B. Klempa, O. Kershaw, A. S. Endres, U. Raab, H. H. Neumayer, H. Meisel, and S. Modrow. 2005. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. J. Med. Virol. 75:161-169.
19. Miyagawa, E., T. Yoshida, H. Takahashi, K. Yamaguchi, T. Nagano, Y. Kiriyama, K. Okochi, and H. Sato. 1999. Infection of the erythroid cell line, KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity. J. Virol. Methods 83:45-54.
20. Mori, J., P. Beattie, D. W. Melton, B. J. Cohen, and J. P. Clewley. 1987. Structure and mapping of the DNA of human parvovirus B19. J. Gen. Virol. 68:2797-2806.
21. Nguyen, Q. T., C. Sifer, V. Schneider, F. Bernaudin, V. Auguste, and A. Garbarg-Chenon. 1998. Detection of an erythrovirus sequence distinct from B19 in a child with acute anaemia. Lancet 352:1524.
22. Nguyen, Q. T., C. Sifer, V. Schneider, X. Allaume, A. Servant, F. Bernaudin, V. Auguste, and A. Garbarg-Chenon. 1999. Novel human erythrovirus associated with transient aplastic anemia. J. Clin. Microbiol. 37:2483-2487.
23. Nguyen, Q. T., S. Wong, E. D. Heegaard, and K. E. Brown. 2002. Identification and characterization of a second novel human erythrovirus variant, A6. Virology 301:374-380.
24. Ozawa, K., and N. Young. 1987. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J. Virol. 61:2627-2630.
25. Saikawa, T., S. Anderson, M. Momoeda, S. Kajigaya, and N. S. Young. 1993. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J. Virol. 67:3004-3009.
26. Saldanha, J., N. Lelie, M. W. Yu, and A. Heath. 2002. Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques. Vox Sang. 82:24-31.
27. Sato, H., J. Hirata, N. Kuroda, H. Shiraki, Y. Maeda, and K. Okochi. 1991. Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies. J. Virol. 65:5485-5490.
28. Schneider, B., M. Becker, H. H. Brackmann, and A. M. Eis-Hubinger. 2004. Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2. Thromb. Haemost. 92:838-845.
29. Servant, A., S. Laperche, F. Lallemand, V. Marinho, M. G. De Saint, J. F. Meritet, and A. Garbarg-Chenon, 2002. Genetic diversity within human erythroviruses: identification of three genotypes. J. Virol. 76:9124-9134.
30. Shade, R. O., M. C. Blundell, S. F. Cotmore, P. Tattersall, and C. R. Astell. 1986. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J. Virol. 58: 921-936.
31. Spearman, C. 1908. The method of right and wiong cases ("constant stimuli") without Gauss's formulae. Br. J. Physiol. 2:227-242.
32. Strassheim, M. L., A. Gruenberg, P. Veijalainen, J. Y. Sgro, and C. R. Parrish. 1994. Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid. Virology 198:175-184.
33. Weimer, T., S. Streichert, C. Watson, and A. Gröner. 2001. High-liter screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation. Transfusion 41:1500-1504.
34. Wong, S., N. S. Young, and K. E. Brown. 2003. Prevalence of parvovirus B19 in liver tissue; no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J. Infect. Dis. 187:1581-1586.
35. Yoshimoto, K., S. Rosenfeld, N. Frickhofen, D. Kennedy, R. Hills, S. Kajigaya, and N. S. Young. 1991. A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response. J. Virol. 65:7056-7060.
36. Young, N. S., and K. E. Brown. 2004. Parvovirus B19. N. Engl. J. Med. 350:586-597.37.
37. Zhi, H., Z. Zádori, K. E. Brown, and P. Tijssen. 2004. Construction and sequencing of an infectious clone of the human parvovirus B19. Virology 318:142-152.